placebo s.c.

DRUG2 trials

Sponsors

IBSA Institut Biochimique SA, Novartis Pharmaceuticals

Conditions

Dental PainLupus Nephritis

Phase 3

Evaluation of the Efficacy and Safety of Diclofenac HPBCD 25, 50 mg/ml in the Treatment of Post-surgical Pain Following Dental Surgery

CompletedNCT00942448

IBSA Institut Biochimique SADental Pain

Start: 2009-09-30End: 2010-04-30Updated: 2013-01-28

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

Active, not recruitingNCT05126277

Novartis PharmaceuticalsLupus Nephritis

Start: 2022-07-14End: 2031-02-04Updated: 2026-08-21